Simplex Trading’s Albany Molecular Research Inc AMRI Stock Holding History

Simplex Trading’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-107	Closed	-$10K	–	7233
2017 Q2	$10K	Buy	107 +67	+168%	+$1.22K	﹤0.01%	4035
2017 Q1	$4K	Buy	+40	New	+$655	﹤0.01%	4893
2016 Q4	–	Sell	-42	Closed	-$1K	–	7057
2016 Q3	$1K	Buy	42 +23	+121%	+$341	﹤0.01%	5622
2016 Q2	$2K	Buy	+19	New	+$277	﹤0.01%	5127

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Simplex Trading's AMRI Position: Q3 2016 in Review

Simplex Trading sold out of Albany Molecular Research Inc (AMRI) in Q3 2016, closing a stake of 622 shares — an estimated $9.21K sold.

Simplex Trading first reported a position in AMRI in Q4 2014 and held it in 4 quarters. The position peaked at $270K in Q4 2014. 137 funds tracked by Wall St. Rank hold AMRI as of Q3 2016.

Simplex Trading reported no remaining Albany Molecular Research Inc position as of Q3 2016 after selling out during the quarter.
Simplex Trading sold 622 Albany Molecular Research Inc shares in Q3 2016, an estimated $9.21K.
Simplex Trading first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 4 quarters.
Simplex Trading's Albany Molecular Research Inc position peaked at $270K in Q4 2014.
137 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2016.

Based on Simplex Trading's 13F filing for Q3 2016, filed 7 Oct 2016.